Compare · HDSN vs STE
HDSN vs STE
Side-by-side comparison of Hudson Technologies Inc. (HDSN) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- HDSN operates in Consumer Discretionary, while STE operates in Health Care - the two are in different parts of the market.
- STE is the larger of the two at $21.26B, about 81.9x HDSN ($259.6M).
- HDSN has been more active in the news (10 items in the past 4 weeks vs 1 for STE).
- STE has more recent analyst coverage (16 ratings vs 11 for HDSN).
- Company
- Hudson Technologies Inc.
- STERIS plc (Ireland)
- Price
- $6.18-2.06%
- $217.88-1.46%
- Market cap
- $259.6M
- $21.26B
- 1M return
- -
- +5.46%
- 1Y return
- -
- -3.39%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 10
- 1
- Recent ratings
- 11
- 16
Hudson Technologies Inc.
Hudson Technologies, Inc. a refrigerant services company, provides solutions to recurring problems within the refrigeration industry primarily in the United States. The company's products and services include refrigerant and industrial gas sales; refrigerant management services consisting primarily of reclamation of refrigerants, re-usable cylinder refurbishment, and hydrostatic testing services; and RefrigerantSide services comprising system decontamination to remove moisture, oils, and other contaminants. It also offers SmartEnergy OPS service, a web-based real time continuous monitoring service; and Chiller Chemistry and Chill Smart services. In addition, the company participates in the generation of carbon offset projects. It serves commercial, industrial, and governmental customers, as well as refrigerant wholesalers, distributors, contractors, and refrigeration equipment manufacturers. Hudson Technologies, Inc. was founded in 1991 and is headquartered in Pearl River, New York.
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest HDSN
- Amendment: SEC Form SCHEDULE 13G/A filed by Hudson Technologies Inc.
- Large owner Hartree Partners, Lp bought $31,352 worth of shares (5,234 units at $5.99), increasing direct ownership by 0.11% to 4,976,536 units (SEC Form 4)
- Large owner Hartree Partners, Lp bought $4,477,207 worth of shares (764,202 units at $5.86), increasing direct ownership by 18% to 4,971,302 units (SEC Form 4)
- New insider Hartree Partners, Lp claimed ownership of 4,207,100 shares (SEC Form 3)
- Director Sheriff Alan was granted 3,219 shares, increasing direct ownership by 35% to 12,484 units (SEC Form 4)
- Director Prouty Eric A was granted 4,440 shares, increasing direct ownership by 3% to 158,292 units (SEC Form 4)
- SEC Form 4 filed by Director Parrillo Richard
- Director Mansy Loan Nguyen was granted 8,881 shares, increasing direct ownership by 35% to 34,476 units (SEC Form 4)
- SEC Form 4 filed by Director Bulgarino Nicole E
- Director Feeler Jeffrey R was granted 3,219 shares, increasing direct ownership by 35% to 12,384 units (SEC Form 4)
Latest STE
- Director Sohi Mohsen exercised 3,781 units of Ordinary Shares at a strike of $71.40 and covered exercise/tax liability with 1,837 units of Ordinary Shares, increasing direct ownership by 9% to 24,305 units (SEC Form 4)
- SEC Form 11-K filed by STERIS plc (Ireland)
- Sr. VP, Gen Counsel, and Sec. Zangerle John Adam sold $296,968 worth of Ordinary Shares (1,419 units at $209.28), decreasing direct ownership by 4% to 35,259 units (SEC Form 4)
- SEC Form 144 filed by STERIS plc (Ireland)
- Sr. VP, Gen Counsel, and Sec. Zangerle John Adam covered exercise/tax liability with 401 units of Ordinary Shares, decreasing direct ownership by 1% to 36,678 units (SEC Form 4)
- V.P. & Corporate Treasurer Tamaro Renato covered exercise/tax liability with 65 units of Ordinary Shares, decreasing direct ownership by 1% to 6,194 units (SEC Form 4)
- Sr. VP and GM, Life Sciences Madsen Julia covered exercise/tax liability with 195 units of Ordinary Shares, decreasing direct ownership by 2% to 12,257 units (SEC Form 4)
- SVP & GM, AST Kohler Kenneth E covered exercise/tax liability with 150 units of Ordinary Shares, decreasing direct ownership by 1% to 11,332 units (SEC Form 4)
- SVP & Chief HRO Fraser Mary Clare covered exercise/tax liability with 600 units of Ordinary Shares, decreasing direct ownership by 4% to 13,716 units (SEC Form 4)
- President and CEO Carestio Daniel A covered exercise/tax liability with 1,889 units of Ordinary Shares and sold $946,799 worth of Ordinary Shares (4,428 units at $213.82), decreasing direct ownership by 9% to 63,647 units (SEC Form 4)